Mike Pintek

Mike Pintek is the president of Nuclear & Precision Health Solutions at Cardinal Health. Nuclear & Precision Health Solutions develops, manufactures, compounds, dispenses and delivers time-critical patient-specific doses. Prior to assuming the role of president in August 2021, Mike was senior vice president of Commercial Operations and Business Development for the Nuclear & Precision Health Solutions business where he led all aspects of the commercial and business development operating functions including strategy development, sales, marketing, pricing, partner management, business intelligence and analytics. Mike has deep and broad global experience in the healthcare and life science industries. Before joining Cardinal Health, he served as chief operating officer at Luminex Corporation until 2014, where his responsibilities encompassed all aspects of the company’s operating functions. He also held several senior leadership positions of increasing responsibility at Roche, including his last position as head of Roche’s Global Transfusion Medicine business. Additionally, he has served in leadership roles with Ventana Medical Systems and Abbott Laboratories’ Diagnostics Division. Mike serves on the board of directors for the Cardinal Health Foundation and the Council on Radionuclides & Radiopharmaceuticals. He also serves as an Advisory Board Member for the Society of Nuclear Medicine and Molecular Imaging Value Initiative Industry Alliance. Additionally, Mike serves as the executive sponsor for the Cardinal Health Disability Advocates Network employee resource group. Mike earned a bachelor’s degree in business administration from Central Michigan University and has successfully completed executive education programs at the University of Chicago Booth School of Business.